Popular on s4story
- Akiti the Hunter Launches Mission to Deliver One Million Books to One Million Children Worldwide - 105
- Sun Gate Golf Retirement Community Doesn't have a Shuffleboard. It Solves Murder Mysteries - 102
- Intuitive Numerologist, Yvonne Sullivan, Publishes the Ultimate Guide to the NOC Divination System - 101
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
- Johnnie Mandela Releases THOUGHT in the Age of AI
- Share Your Story Event: Your Voice, Your Story
- Wilber Chitambo's From Pain to Purpose: A Healing Journey Offers a Powerful Testament to Healing
- New Book Asks Caregivers to Look Past Dementia—and See the Person
- New Book Revisits Berny Dohrmann, CEO Space and the People Who Powered The Space
Similar on s4story
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Mom Era, Still That Girl: Family Art Tees 25% Off
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
Infertility Trial Focused on Men's Antioxidant Intake Helps Couple Conceive
S For Story/10284174
After eight years of trying to conceive on their own, a couple gets pregnant within three months of enrolling in an infertility trial at Carolinas HealthCare System's CMC Women's Institute.
CHARLOTTE, N.C. - March 10, 2017 - s4story -- First Comes Love, Then Comes Baby (Maybe)
Tasha Wygal, a cosmetologist, and Caleb Wygal, an author and entrepreneur, got married in 2002. "It was literally love at first sight," says Caleb. "When I saw her I said to myself, 'That's the girl I'm going to marry.'"
The Wygals originally started thinking about starting a family in 2009. When traditional conception methods didn't work, they decided to seek out a fertility expert's opinion.
The couple was referred to Rebecca S. Usadi, MD, an associate director of reproductive endocrinology at CMC Women's Institute. After the initial consultation, Dr. Usadi explained that the couple fell into the category of unexplained infertility and thought they might be a good fit for a clinical trial called MOXI (Males, Antioxidants and Infertility).
More on S For Story
Infertility Trial Proves Fruitful
MOXI is a double-blind, placebo-controlled trial that examines whether mildly infertile males who take a twice daily dose of antioxidants in pill form will experience a boost in fertility. The hope of the trial is that the antioxidants will prove to improve sperm quality, resulting in higher fertilization rates and improved embryo development.
The study is also looking to see if the antioxidants can improve the quality of the sperm, which would allow for couples with unexplained infertility to use less intensive therapies to get pregnant. Another upside of the MOXI trial is a cost savings on expensive infertility treatments. The trial covers the cost of three clomiphene (medication used to treat infertility) and intrauterine insemination (a fertility treatment) cycles for qualifying couples.
Just a few weeks into the trial, Tasha had a feeling that she might be pregnant. Her period was a few days late, and she had serious heartburn.
"Seeing as how I may have been taking the real MOXI and not the placebo, I just hoped that it might have done the trick."
More on S For Story
Then, a visit with Dr. Usadi confirmed what they suspected – Tasha was indeed pregnant. The couple was ecstatic, apprehensive and nervous all at once.
About MOXI
CMC Women's Institute is one of eight sites across the country participating in the MOXI Trial, and is the only place in Charlotte to offer couples this opportunity. The trial is led by the NIH Reproductive Medicine Network and is expected to last two to three years.
Recently, another couple enrolled in the trial confirmed that they are pregnant.
To learn more about MOXI, call 704-355-2949 or email Kathleen.ramsey@carolinashealthcare.org.
http://blogs.carolinas.org/dailydose/infertility-trial-focused-on-mens-antioxidant-intake-helps-couple-conceive/
Tasha Wygal, a cosmetologist, and Caleb Wygal, an author and entrepreneur, got married in 2002. "It was literally love at first sight," says Caleb. "When I saw her I said to myself, 'That's the girl I'm going to marry.'"
The Wygals originally started thinking about starting a family in 2009. When traditional conception methods didn't work, they decided to seek out a fertility expert's opinion.
The couple was referred to Rebecca S. Usadi, MD, an associate director of reproductive endocrinology at CMC Women's Institute. After the initial consultation, Dr. Usadi explained that the couple fell into the category of unexplained infertility and thought they might be a good fit for a clinical trial called MOXI (Males, Antioxidants and Infertility).
More on S For Story
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Governor Laura Kelly Proclaims September 26 University Press of Kansas Day
- Childhood nickname inspires whimsical Australian children's book The Wonky Woo
- La Quema del Año Viejo en Venezuela explora una tradición de memoria
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
Infertility Trial Proves Fruitful
MOXI is a double-blind, placebo-controlled trial that examines whether mildly infertile males who take a twice daily dose of antioxidants in pill form will experience a boost in fertility. The hope of the trial is that the antioxidants will prove to improve sperm quality, resulting in higher fertilization rates and improved embryo development.
The study is also looking to see if the antioxidants can improve the quality of the sperm, which would allow for couples with unexplained infertility to use less intensive therapies to get pregnant. Another upside of the MOXI trial is a cost savings on expensive infertility treatments. The trial covers the cost of three clomiphene (medication used to treat infertility) and intrauterine insemination (a fertility treatment) cycles for qualifying couples.
Just a few weeks into the trial, Tasha had a feeling that she might be pregnant. Her period was a few days late, and she had serious heartburn.
"Seeing as how I may have been taking the real MOXI and not the placebo, I just hoped that it might have done the trick."
More on S For Story
- New 666-Page Book Examines America, Israel, Iran, the Middle East, History—and Biblical Prophecy
- Pittsburgh Creators Launch Clever New Children's Book, "The Sock Sleuth!"
- "The Man From Rock Bottom" Wins 2026 FAPA President's Book Award
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- History Matters - The Return of the Lewis and Clark Expedition, 1806
Then, a visit with Dr. Usadi confirmed what they suspected – Tasha was indeed pregnant. The couple was ecstatic, apprehensive and nervous all at once.
About MOXI
CMC Women's Institute is one of eight sites across the country participating in the MOXI Trial, and is the only place in Charlotte to offer couples this opportunity. The trial is led by the NIH Reproductive Medicine Network and is expected to last two to three years.
Recently, another couple enrolled in the trial confirmed that they are pregnant.
To learn more about MOXI, call 704-355-2949 or email Kathleen.ramsey@carolinashealthcare.org.
http://blogs.carolinas.org/dailydose/infertility-trial-focused-on-mens-antioxidant-intake-helps-couple-conceive/
Source: Carolinas Healthcare System
0 Comments
Latest on S For Story
- New Book Announcement - Nixon's War with Students: Campus Unrest in the Vietnam Era
- New Book Announcement - Shokhí: A Kanza Relative, a Monument, and Rematriation
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Michelle Carey Releases Maryland Political Thriller, The Crofton Triangle
- Terry E. Gunn Releases New Children's Picture Book A Silly DOG Named Klaus
- She Ran Hospitals Before Learning What Leadership Cost Her. Her New Book Helps Other Women Avoid It
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- "For the Love of God" Audiobook by Michael Finney Now Available
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Speak Empowered Welcomes Author Eli Brackenbury as First Speaker in Faith & Purpose Category
- BookBuzz Interviews Author Daniela Hristova About Her New Memoir – Fluent in Faux Pas